These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 24083636)
1. Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome. Rodriguez-Tolrà J; Torremadé Barreda J; del Rio L; di Gregorio S; Franco Miranda E Aging Male; 2013 Dec; 16(4):184-90. PubMed ID: 24083636 [TBL] [Abstract][Full Text] [Related]
2. Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome. Rodriguez-Tolrà J; Torremadé J; di Gregorio S; Del Rio L; Franco E Andrology; 2013 Jul; 1(4):570-5. PubMed ID: 23686863 [TBL] [Abstract][Full Text] [Related]
3. Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study. Bouloux PM; Legros JJ; Elbers JM; Geurts TB; Kaspers MJ; Meehan AG; Meuleman EJ; Aging Male; 2013 Jun; 16(2):38-47. PubMed ID: 23581697 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale. Ho CC; Tong SF; Low WY; Ng CJ; Khoo EM; Lee VK; Zainuddin ZM; Tan HM BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649 [TBL] [Abstract][Full Text] [Related]
6. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients. Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433 [TBL] [Abstract][Full Text] [Related]
7. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel. Swerdloff RS; Wang C Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501 [TBL] [Abstract][Full Text] [Related]
8. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals. Mueller A; Haeberle L; Zollver H; Claassen T; Kronawitter D; Oppelt PG; Cupisti S; Beckmann MW; Dittrich R J Sex Med; 2010 Sep; 7(9):3190-8. PubMed ID: 20584125 [TBL] [Abstract][Full Text] [Related]
9. Short term testosterone replacement therapy improves libido and body composition. Andrade ES; Clapauch R; Buksman S Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):996-1004. PubMed ID: 20126853 [TBL] [Abstract][Full Text] [Related]
10. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271 [TBL] [Abstract][Full Text] [Related]
11. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499 [TBL] [Abstract][Full Text] [Related]
12. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study. Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM; Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706 [TBL] [Abstract][Full Text] [Related]
13. Influence of baseline serum testosterone on changes in body composition in response to testosterone therapy. Di Sante S; Conners WP; Morgentaler A J Sex Med; 2012 Feb; 9(2):585-93. PubMed ID: 22145684 [TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Morrison BF; Reid M; Madden W; Burnett AL Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509 [TBL] [Abstract][Full Text] [Related]